ANGO vs PATH
AngioDynamics Inc (ANGO) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ANGO currently screens at market cap $378.5M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ANGO and PATH stock pages for the full models.
Not investment advice.